Euro-Med Laboratories Phil., Inc. (PSE: EURO)

Market Cap	2.92B
Revenue (ttm)	5.63B
Net Income (ttm)	323.72M
Shares Out	4.11B
EPS (ttm)	0.08
PE Ratio	9.02
Forward PE	n/a
Dividend	0.04 (4.73%)
Ex-Dividend Date	n/a

Volume	9,000
Open	0.750
Previous Close	0.740
Day's Range	0.710 - 0.750
52-Week Range	0.700 - 0.790
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About EURO

Euro-Med Laboratories Phil., Inc. manufactures and sells various pharmaceutical products in the Philippines and internationally. It manufactures and distributes large and small volume parenterals that are used as solvents for other drugs; sterile water for injection; and other solutions for ophthalmic, inhalation, irrigation, and dialysis. The company also offers specialty fluids comprising dialysis solutions for the treatment of acute or chronic renal failure; hemodialysis solution, a concentrated solution of electrolytes in water for injectio...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1988
• Employees: 1,604
• Stock Exchange: Philippine Stock Exchange
• Ticker Symbol: EURO

Financial Performance

In 2023, EURO's revenue was 5.26 billion, an increase of 24.62% compared to the previous year's 4.22 billion. Earnings were 289.95 million, an increase of 45.06%.